Catharina Svanborg
Vermogen: 37 M $ op 31-05-2026
Vermogen: 37 M $ op 31-05-2026
Catharina Svanborg is the founder of Hamlet BioPharma AB, founded in 1999, holding the title of Chairman since 2025.
Dr. Svanborg is the founder of Linnane Pharma AB, founded in 2013, holding the title of Chairman since 2013.
Dr. Svanborg is the founder of SelectImmune Pharma AB, founded in 2017, holding the title of Chairman since 2017.
Dr. Svanborg currently holds the position of Director at the Royal Swedish Academy of Engineering Sciences since 1997.
Dr. Svanborg currently holds the position of Professor-Clinical Immunology at the University of Lund since 1989.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2025 | 45.976.673 ( 31,77% ) | 37 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| HAMLET PHARMA AB (PUBL) | Oprichter | 29-03-1999 |
| SELECTIMMUNE PHARMA AB (PUBL) | Voorzitter | 10-02-2017 |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-1989 |
Linnane Pharma AB
Linnane Pharma AB BiotechnologyHealth Technology Develops scientific discoveries into novel drugs | Oprichter | 19-11-2013 |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services Operates engineering science academy | Directeur/Bestuurslid | 01-01-1997 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services Operates engineering science academy | Commercial Services |
Hamlet BioPharma AB
Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients | Health Technology |
Linnane Pharma AB
Linnane Pharma AB BiotechnologyHealth Technology Develops scientific discoveries into novel drugs | Health Technology |
SelectImmune Pharma AB
SelectImmune Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and manufactures immune enhancers to complement antibiotics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau